Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection
Elena Angeli(Luigi Sacco Hospital), G. Gubertini, Riccardo De Giorgi(Warneford Hospital), Massimo Andreoni(University of Rome Tor Vergata), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Monica Schiavini(ASST Fatebenefratelli Sacco), Anna Orani(Alessandro Manzoni Hospital), R Carbone(Luigi Sacco Hospital), Giuliano Rizzardini, A. Cargnel(University of Milan), Annalisa Mainini(Luigi Sacco Hospital)
Cited by 5
Related Papers
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
|New England Journal of Medicine|2022|264
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168
High Seroprevalence of Antibodies to Human Herpesvirus-8 in Egyptian Children: Evidence of Nonsexual Transmission
|JNCI Journal of the National Cancer Institute|1999|140